AstraZeneca names Rick R. Suarez as US President and Head of US BioPharmaceuticals Business Unit
Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
Pravesh brings with him over 29 years of experience in leading complex manufacturing operations and driving operational excellence
Before this appointment, he served as the Secretary in the Department of Land Resources, Ministry of Rural Development
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Consolidated revenue from operations stood at Rs. 111.05 crore
The FDA setback highlights ongoing tensions between patient needs, regulatory processes, and the use of real-world evidence in evaluating treatments for rare diseases
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Subscribe To Our Newsletter & Stay Updated